MedTech Week Magazine 2018 At a glance
Highlights from the 3rd Edition of the Award-Winning MedTech Week Magazine
784,154
Twitter accounts reached
#MedTechWeek used 3000+ times
I take this opportunity to sincerely thank all our members for their enormous efforts in making the role of medical technologies more widely known during MedTech Week 2018 last June.
Now in it's fourth year, MedTech Week brings out the best in the companies and national associations that represent our industry. Together, they have served up dozens of examples in unwavering ingenuity to illustrate the value of medtech.
20
Countries
Engaged
50
Members
Involved
16
External
Partners
2
million+
views
18,000
website visits
49,000
video views
Bringing Sound & Vision to the message
Articles
Keeping you running
MedTech Europe go the extra mile in Brussels
Hidden heroes
MedTech is all around us but often goes unseen – and undervalued
Virus or bacterium?
Knowing the cause of an illness helps accelerate recovery, avoids waste of resources and reduces antimicrobial resistance
Sports therapy
Exploring the connection between sport, health and medtech
Race against time
The next French medtech Unicorns
Young companies rewarded for innovative new creations
Boot Camp
Start-ups find inspiration in six-month accelerator program
Food for thought
Access to innovation was on the menu at ‘parliamentary breakfast’
Extraordinary stories, ordinary lives
Meet the patients for whom medtech is a way of life
Tomorrow’s world
Digital health will boost patient safety and tackle infection control
Perspectives
‘Dialysis at home: savings lives, preserving autonomy’
Dialysis can be essential to the wellbeing of people living with kidney failure.
‘Committed to protect our health from Roberto Bertollini, HFE honorary president’
‘Thinking smarter & working harder to deliver Value-Based Healthcare – Together’
Michelle Brennan, Chair of the Board of MedTech Europe and Company Group Chair, Johnson & Johnson Medical Devices Companies, Europe, Middle East & Africa (EMEA)
‘Artificial intelligence: The next revolution in healthcare?’
At the turn of the century, healthcare companies were at the zenith of an ‘innovate-manufacture-sell’ business model.
‘How digital technologies will reshape musculoskeletal healthcare’
Digital technologies provide an opportunity to move musculoskeletal care to the heart of value-based healthcare. MedTech Views spoke to Satschin Bansal of Zimmer Biomet about some of the innovations that will change the field.
‘Colorectal cancer: don’t delay diagnosis’
Colorectal cancer is the third most common cancer in the world and the second most common in Europe. The disease can be fatal but early diagnosis and intervention are improving outcomes for patients.
‘Diagnosing STIs: faster tests for chlamydia and gonorrhoea can help reduce the spread of disease’
Advances in diagnostic technologies give patients same-day test results for sexually transmitted infections (STIs) such as chlamydia and gonorrhoea.
‘Asthma is a struggle – imagine carrying a 50kg stone around all day’
For people living with severe asthma, daily tasks can be a real challenge.
‘Digital health is here – time to take the lead’
How do we prepare Europe for future technologies?
‘Diagnosing Deafness’
Timely cochlear implant surgery can significantly help deaf children’s speech, language, cognitive and socio-emotional behaviour.
‘Dialysis at home: savings lives, preserving autonomy’
Dialysis can be essential to the wellbeing of people living with kidney failure.
Dialysis can be essential to the wellbeing of people living with kidney failure. However, many patients have concerns about the impact of regular dialysis on their daily activity. Will they lose independence? Will it affect their family and professional lives?
Today there are technological solutions that allow patients to adapt their treatment to their way of life – and not vice versa. With peritoneal dialysis, the therapy can be delivered at home, without needing to go to a medical centre. For suitable patients, this enables dialysis to be performed while they sleep, thus allowing them to maintain their personal and work activity by day.
Web connectivity platforms enable remote monitoring, so that the process can be supervised and controlled by specialists. This provides patients with security and confidence.
Patients choice
It is important that patients participate actively in the choice of their treatment, as they know best how dialysis will impact their daily lives. In Spain, a multi-stakeholder organisation – the Support Group for the Development of Peritoneal Dialysis (GADDPE) – was established in 2009 to raise awareness of the treatment options available to people with kidney failure.
The group has highlighted the low uptake of peritoneal dialysis in Spain in several ways, including through a recent video by the EuropaPress.tv agency in Madrid. The short film features testimony from patients, as well as a doctor, about dialysis and its impact on patients’ lives. The goal is to illustrate why some patients might choose to have peritoneal dialysis at home.
Research has shown that when kidney patients receive adequate information about the available treatments, 50% of those who start dialysis choose peritoneal dialysis at home. However, figures of the use of peritoneal dialysis are strikingly low in Spain: only 5% of patients who require renal replacement therapy use this option (11.43 % of those on dialysis).
GADDPE aims to improve access to information on treatment options in collaboration with health professionals, patients and the wider healthcare system. The group says it has seen some improvement in recent years, but much work remains to be done.
In addition to home dialysis technology, GADDPE would like to see new technological solutions that improve communication between hospitals and patients’ home. Not only would this offer additional peace of mind to patients and continue to optimise outcomes, it would offer two things that are sometimes missing from renal replacement therapy - choice and autonomy.
Juan Carlos Julian
Director General, Federación Nacional ALCER
Bachelor in Psychology from the Complutense University of Madrid, specialized in Psychosociology of work and organizations. Postgraduate courses in Human Resources management, Social and labor integration of people with disabilities and in Management of Patient Organizations. Collaborating Professor of the European University of Madrid in the "Nurse Dialysis Expert Course" on psychosocial aspects, emotional management and decision making of people with chronic kidney diseases. He has published in different journals in the field of Nephrology studies on the keys in the information processes in chronic kidney disease, social work situation of people with kidney disease and the associated social cost. Collaborator of the Autonomous University of Madrid in the measurement of quality of life related to health in people with chronic kidney disease and renal replacement therapy.
